Find more Myriad info as well as links to National Institutes of Health resources.
The goal of carrier screening is to detect couples who are at risk of passing down serious inherited conditions.
Universal carrier screening for cystic fibrosis and spinal muscular atrophy is recommended by American College of Medical Genetics (ACMG) and American College of Obstetricians and Gynecologists. (ACOG).1,2
We’ve designed the Foresight Carrier Screen to maximize detection rates for the diseases that matter the most.
Unmatched At-Risk Couple Detection Have the utmost confidence you aren’t missing couples at risk with the highest published at-risk couple detection rate for serious inherited conditions (1 in 22 couples)3
Superior Technology Unmatched detection rates for the vast majority of genes on our panel (>99% across ethnicities) means you can trust both positive and negative results.
Seamless Patient Care With Myriad Complete™ Whether its automated results reporting and tracking, merged reports for couples, or on-demand patient education, our solutions are designed to help the patient through the screening process.